159 related articles for article (PubMed ID: 25681288)
21. Potentiation of mitomycin C tumoricidal activity for transitional cell carcinoma by histone deacetylase inhibitors in vitro.
Deb AA; Wilson SS; Rove KO; Kumar B; Koul S; Lim DD; Meacham RB; Koul HK
J Urol; 2011 Dec; 186(6):2426-33. PubMed ID: 22019171
[TBL] [Abstract][Full Text] [Related]
22. Silencing survivin expression inhibits the tumor growth of non-small-cell lung cancer cells in vitro and in vivo.
Zhang K; Li Y; Liu W; Gao X; Zhang K
Mol Med Rep; 2015 Jan; 11(1):639-44. PubMed ID: 25333812
[TBL] [Abstract][Full Text] [Related]
23. siRNA-mediated down-regulation of survivin inhibits bladder cancer cell growth.
Ning S; Fuessel S; Kotzsch M; Kraemer K; Kappler M; Schmidt U; Taubert H; Wirth MP; Meye A
Int J Oncol; 2004 Oct; 25(4):1065-71. PubMed ID: 15375557
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic efficacy of a lipid-based prodrug of mitomycin C in pegylated liposomes: studies with human gastro-entero-pancreatic ectopic tumor models.
Gabizon A; Amitay Y; Tzemach D; Gorin J; Shmeeda H; Zalipsky S
J Control Release; 2012 Jun; 160(2):245-53. PubMed ID: 22134116
[TBL] [Abstract][Full Text] [Related]
25. [Cytotoxic effect of oncolytic virus combined with mitomycin against human bladder cancer cells in vitro and in vivo].
Zhao GZ; Tan WL; Zheng SB; Wu YD; Xie Y; Zhu WH
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1623-5, 1628. PubMed ID: 17121717
[TBL] [Abstract][Full Text] [Related]
26. Survivin knockdown by short hairpin RNA abrogates the growth of human hepatocellular carcinoma xenografts in nude mice.
Zhang R; Ma L; Zheng M; Ren J; Wang T; Meng Y; Zhao J; Jia L; Yao L; Han H; Li K; Yang A
Cancer Gene Ther; 2010 Apr; 17(4):275-88. PubMed ID: 19876077
[TBL] [Abstract][Full Text] [Related]
27. Growth inhibition induced by short hairpin RNA to silence survivin gene in human pancreatic cancer cells.
Shen YM; Yang XC; Song ML; Qin CH; Yang C; Sun YH
Hepatobiliary Pancreat Dis Int; 2010 Feb; 9(1):69-77. PubMed ID: 20133233
[TBL] [Abstract][Full Text] [Related]
28. Knockdown of survivin expression by siRNAs enhances chemosensitivity of prostate cancer cells and attenuates its tumorigenicity.
Shen J; Liu J; Long Y; Miao Y; Su M; Zhang Q; Han H; Hao X
Acta Biochim Biophys Sin (Shanghai); 2009 Mar; 41(3):223-30. PubMed ID: 19280061
[TBL] [Abstract][Full Text] [Related]
29. Intravesical chemotherapy of high-grade bladder cancer with HTI-286, a synthetic analogue of the marine sponge product hemiasterlin.
Hadaschik BA; Adomat H; Fazli L; Fradet Y; Andersen RJ; Gleave ME; So AI
Clin Cancer Res; 2008 Mar; 14(5):1510-8. PubMed ID: 18316576
[TBL] [Abstract][Full Text] [Related]
30. Synergistic effects of 7-O-geranylquercetin and siRNAs on the treatment of human breast cancer.
Zuo J; Jiang Y; Zhang E; Chen Y; Liang Z; Zhu J; Zhao Y; Xu H; Liu G; Liu J; Wang W; Zhang S; Zhen Y
Life Sci; 2019 Jun; 227():145-152. PubMed ID: 31009625
[TBL] [Abstract][Full Text] [Related]
31. Targeted gene delivery in tumor xenografts by the combination of ultrasound-targeted microbubble destruction and polyethylenimine to inhibit survivin gene expression and induce apoptosis.
Chen ZY; Liang K; Qiu RX
J Exp Clin Cancer Res; 2010 Nov; 29(1):152. PubMed ID: 21092274
[TBL] [Abstract][Full Text] [Related]
32. Novel Survivin-Targeted Small Interfering RNA Delivered by Nanoparticles.
Feng C; Wang T; Zhang Y; Qu K; Tang S
Am J Med Sci; 2017 Nov; 354(5):506-512. PubMed ID: 29173363
[TBL] [Abstract][Full Text] [Related]
33. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
Mizutani Y; Yoshida O; Bonavida B
J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
[TBL] [Abstract][Full Text] [Related]
34. Galactosylated poly(ethylene glycol) methacrylate-st-3-guanidinopropyl methacrylamide copolymers as siRNA carriers for inhibiting Survivin expression in vitro and in vivo.
Wu Y; Qin Z; Ji J; Yang R; Zhang X; Li Y; Yin L; Pu Y; Li X
J Drug Target; 2014 May; 22(4):352-64. PubMed ID: 24405019
[TBL] [Abstract][Full Text] [Related]
35. [Survivin small interfering RNA suppresses the growth of adenoid cystic carcinoma cell xenografts in vivo].
Yang J; Wang X; Xu B; Xiong Y
Hua Xi Kou Qiang Yi Xue Za Zhi; 2009 Aug; 27(4):433-5. PubMed ID: 19769267
[TBL] [Abstract][Full Text] [Related]
36. Treatment of human metastatic transitional cell carcinoma of the bladder in a murine model with the anti-vascular endothelial growth factor receptor monoclonal antibody DC101 and paclitaxel.
Inoue K; Slaton JW; Davis DW; Hicklin DJ; McConkey DJ; Karashima T; Radinsky R; Dinney CP
Clin Cancer Res; 2000 Jul; 6(7):2635-43. PubMed ID: 10914704
[TBL] [Abstract][Full Text] [Related]
37. Induction of apoptosis by survivin silencing through siRNA delivery in a human breast cancer cell line.
Montazeri Aliabadi H; Landry B; Mahdipoor P; Uludağ H
Mol Pharm; 2011 Oct; 8(5):1821-30. PubMed ID: 21838308
[TBL] [Abstract][Full Text] [Related]
38. Enhanced Lysosomal Escape of pH-Responsive Polyethylenimine-Betaine Functionalized Carbon Nanotube for the Codelivery of Survivin Small Interfering RNA and Doxorubicin.
Cao Y; Huang HY; Chen LQ; Du HH; Cui JH; Zhang LW; Lee BJ; Cao QR
ACS Appl Mater Interfaces; 2019 Mar; 11(10):9763-9776. PubMed ID: 30776886
[TBL] [Abstract][Full Text] [Related]
39. Lentivirus-mediated siRNA targeting VEGF inhibits gastric cancer growth in vivo.
Sun P; Yu H; Zhang WQ; Hu M; Lv R
Oncol Rep; 2012 Nov; 28(5):1687-92. PubMed ID: 22895814
[TBL] [Abstract][Full Text] [Related]
40. siRNA-mediated inhibition of antiapoptotic genes enhances chemotherapy efficacy in bladder cancer cells.
Kunze D; Erdmann K; Froehner M; Wirth MP; Fuessel S
Anticancer Res; 2012 Oct; 32(10):4313-8. PubMed ID: 23060552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
